{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:27Z","timestamp":1792813227515,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Structural Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.crstbi.2026.100198","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:51:00Z","timestamp":1788882660000},"page":"100198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Computational evaluation of EPA-PC binding to GCase in neuronopathic Gaucher disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3445-2662","authenticated-orcid":false,"given":"Ruchita","family":"Nagori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush Kant","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-5227","authenticated-orcid":false,"given":"Usha","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crstbi.2026.100198_bib1","series-title":"Biomolecular Forms and Functions: a Celebration of 50 Years of the Ramachandran Map","author":"Bansal","year":"2013"},{"issue":"9","key":"10.1016\/j.crstbi.2026.100198_bib2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1060028013500469","article-title":"Gaucher disease and its treatment options","volume":"47","author":"Bennett","year":"2013","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cpdd.84","article-title":"Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects","volume":"3","author":"Braeckman","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100198_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/jcm12010085","article-title":"Global incidence and prevalence of gaucher disease: a targeted literature review","volume":"12","author":"Castillon","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/molecules29020453","article-title":"Identification of GM1-Ganglioside secondary accumulation in fibroblasts from neuropathic gaucher patients and effect of a trivalent trihydroxypiperidine iminosugar compound on its storage reduction","volume":"29","author":"Ceni","year":"2024","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.crstbi.2026.100198_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-0004.2007.00769.x","article-title":"The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease","volume":"71","author":"Charrow","year":"2007","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.crstbi.2026.100198_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/md19060306","article-title":"Advances in technologies for highly active Omega-3 fatty acids from krill oil: clinical applications","volume":"19","author":"Colletti","year":"2021","journal-title":"Mar. Drugs"},{"issue":"17","key":"10.1016\/j.crstbi.2026.100198_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-12-758409","article-title":"Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy","volume":"129","author":"Cox","year":"2017","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.crstbi.2026.100198_bib9","first-page":"S1","article-title":"Mechanisms of Gaucher disease pathogenesis","volume":"3","author":"Dan John Sillence","year":"2015","journal-title":"\u8f6c\u5316\u533b\u5b66\u5e74\u9274"},{"issue":"4","key":"10.1016\/j.crstbi.2026.100198_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s42995-021-00097-9","article-title":"Study on the effects of the different polar group of EPA-enriched phospholipids on the proliferation and apoptosis in 95D cells","volume":"3","author":"Guo","year":"2021","journal-title":"Mar. Life Sci. Technol."},{"issue":"6","key":"10.1016\/j.crstbi.2026.100198_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher disease in bone: from pathophysiology to practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.crstbi.2026.100198_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/pharmaceutics17060793","article-title":"Terpenes and essential oils in pharmaceutics: applications as therapeutic agents and penetration enhancers with advanced delivery systems for improved stability and bioavailability","volume":"17","author":"Kaspute","year":"2025","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.crstbi.2026.100198_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109139","article-title":"Sphingolipid de novo synthesis is upregulated in a macrophage model of Gaucher disease","volume":"145","author":"Lake","year":"2025","journal-title":"Mol. Genet. Metabol."},{"issue":"8","key":"10.1016\/j.crstbi.2026.100198_bib14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side\u2010chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff\u2010Larsen","year":"2010","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100198_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgme.2009.01.006","article-title":"Participation of asparagine 370 and glutamine 235 in the catalysis by acid \u03b2-glucosidase: the enzyme deficient in Gaucher disease","volume":"97","author":"Liou","year":"2009","journal-title":"Mol. Genet. Metabol."},{"issue":"7","key":"10.1016\/j.crstbi.2026.100198_bib16","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid \u03b2-Glucosidases","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.crstbi.2026.100198_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jff.2016.02.041","article-title":"Eicosapentaenoic acid-containing phosphatidylcholine alleviated lipid accumulation in orotic acid-induced non-alcoholic fatty liver","volume":"23","author":"Liu","year":"2016","journal-title":"J. Funct.Foods"},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.53365\/nrfhh\/144888","article-title":"Design, synthesis, and characterization of novel series of pharmacologically-important sperm-shaped amphiphilic heterocyclic compounds derived from natural palmitic acid","volume":"2","author":"Rabie","year":"2022","journal-title":"Nat. Resour. Hum. Health"},{"issue":"3","key":"10.1016\/j.crstbi.2026.100198_bib22","article-title":"New potential inhibitors of coronaviral main protease CoV-Mpro): Strychnine Bush, pineapple, and ginger could be natural enemies of COVID-19","volume":"9","author":"Rabie","year":"2022","journal-title":"Int. J. New Chem."},{"key":"10.1016\/j.crstbi.2026.100198_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2019.11.010","article-title":"Accurate conventional and microwave-assisted synthesis of galloyl hydrazide","volume":"7","author":"Rabie","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.crstbi.2026.100198_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100055","article-title":"Teriflunomide: a possible effective drug for the comprehensive treatment of COVID-19","volume":"2","author":"Rabie","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"25","key":"10.1016\/j.crstbi.2026.100198_bib23","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1021\/acsomega.1c07095","article-title":"Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease","volume":"7","author":"Rabie","year":"2022","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.crstbi.2026.100198_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12033-022-00551-8","article-title":"Potent dual Polymerase\/Exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 Omicron virus: a promising in Silico\/In vitro repositioning research study","volume":"66","author":"Rabie","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5923\/j.ajoc.20160602.02","article-title":"Design, synthesis, and biological evaluation of novel 5-Substituted-2-(3,4,5-trihydroxyphenyl)-1,3,4-oxadiazoles as potent antioxidants","volume":"6","author":"Rabie","year":"2016","journal-title":"Am. J. Org. Chem."},{"key":"10.1016\/j.crstbi.2026.100198_bib26","article-title":"The isoquinoline derivative \u2018CYNOVID\u2019 as a prospective anti-SARS-CoV-2 agent: an expanded investigative computational study","volume":"12","author":"Rabie","year":"2024","journal-title":"Eur. J. Med. Chem. Rep"},{"issue":"4","key":"10.1016\/j.crstbi.2026.100198_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/17474086.2021.1908120","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"14","author":"Revel-Vilk","year":"2021","journal-title":"Expert Rev. Hematol."},{"issue":"66","key":"10.1016\/j.crstbi.2026.100198_bib28","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1002\/chem.202102359","article-title":"Design, synthesis and structural analysis of glucocerebrosidase imaging agents","volume":"27","author":"Rowland","year":"2021","journal-title":"Chem. Eur J."},{"issue":"W1","key":"10.1016\/j.crstbi.2026.100198_bib29","doi-asserted-by":"crossref","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","article-title":"Plip 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.crstbi.2026.100198_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100198_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40203-018-0039-3","article-title":"Molecular docking and ADME properties of bioactive molecules against human acid-beta-glucosidase enzyme, cause of Gaucher's disease","volume":"6","author":"Subramaniyan","year":"2018","journal-title":"Silico Pharmacol"},{"issue":"7","key":"10.1016\/j.crstbi.2026.100198_bib32","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1039\/D0FO00804D","article-title":"The exogenous natural phospholipids, EPA-PC and EPA-PE, contribute to ameliorate inflammation and promote macrophage polarization","volume":"11","author":"Tian","year":"2020","journal-title":"Food Funct."},{"issue":"16","key":"10.1016\/j.crstbi.2026.100198_bib33","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/cbic.200800304","article-title":"Identification of pharmacological chaperones for gaucher disease and characterization of their effects on \u03b2\u2010Glucocerebrosidase by Hydrogen\/Deuterium Exchange Mass spectrometry","volume":"9","author":"Tropak","year":"2008","journal-title":"Chembiochem"},{"issue":"15","key":"10.1016\/j.crstbi.2026.100198_bib34","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.crstbi.2026.100198_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.crstbi.2026.100198_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MPH.0000000000002506","article-title":"Global epidemiology of gaucher disease: an updated systematic review and meta-analysis","volume":"45","author":"Wang","year":"2023","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100198_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11745-010-3472-6","article-title":"Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba","volume":"46","author":"Winther","year":"2011","journal-title":"Lipids"}],"container-title":["Current Research in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X2600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X2600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:45:58Z","timestamp":1792809958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665928X2600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S2665928X2600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100198","relation":{},"ISSN":["2665-928X"],"issn-type":[{"value":"2665-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational evaluation of EPA-PC binding to GCase in neuronopathic Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Current Research in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100198"}}